These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2920758)
1. New estradiol-linked nitrosoureas: can the pharmacokinetic properties help to explain the pharmacodynamic activities? Betsch B; Berger MR; Spiegelhalder B; Eisenbrand G; Schmähl D Eur J Cancer Clin Oncol; 1989 Jan; 25(1):105-11. PubMed ID: 2920758 [TBL] [Abstract][Full Text] [Related]
2. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites. Betsch B; Berger MR; Spiegelhalder B Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936 [TBL] [Abstract][Full Text] [Related]
3. An oestradiol-linked nitrosourea and site-directed chemotherapy in mammary carcinoma. Betsch B; Berger MR; Spiegelhalder B; Schmähl D; Eisenbrand G Eur J Cancer; 1990; 26(8):895-8. PubMed ID: 2145934 [TBL] [Abstract][Full Text] [Related]
4. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia. Zeller WJ; Schreiber J; Petru E; Eisenbrand G Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608 [TBL] [Abstract][Full Text] [Related]
5. Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions. Berger MR; Floride J; Schmähl D; Schreiber J; Eisenbrand G Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1179-91. PubMed ID: 3816911 [TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man. Petru E; Berger MR; Zeller WJ; Kaufmann M Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940 [TBL] [Abstract][Full Text] [Related]
7. Modulation of cytosolic sexual steroid receptors in autochthonous methylnitrosourea-induced rat mammary carcinoma following application of 2-chloroethylnitrosocarbamoyl-L-alanine linked to oestradiol or dihydrotestosterone. Corr R; Berger MR; Betsch B; Floride JA; Brix HP; Schmähl D Br J Cancer; 1990 Jul; 62(1):42-7. PubMed ID: 2390481 [TBL] [Abstract][Full Text] [Related]
8. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison]. Petru E; Berger MR; Zeller WJ; Kaufmann M Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice. Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705 [TBL] [Abstract][Full Text] [Related]
10. Androgen-linked alkylating agents: biological activity in methylnitrosourea-induced rat mammary carcinoma. Brix HP; Berger MR; Schneider MR; Tang WC; Eisenbrand G J Cancer Res Clin Oncol; 1990; 116(6):538-49. PubMed ID: 2254372 [TBL] [Abstract][Full Text] [Related]
11. Cytostatic activity of steroid linked nitrosoureas. Zeller WJ; Schreiber J; Ho AD; Schmähl D; Eisenbrand G J Cancer Res Clin Oncol; 1984; 108(1):164-8. PubMed ID: 6746709 [TBL] [Abstract][Full Text] [Related]
12. Development of more selective anti-cancer nitrosoureas. Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304 [TBL] [Abstract][Full Text] [Related]
13. Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC). Bibby MC; Double JA J Cancer Res Clin Oncol; 1986; 112(1):47-9. PubMed ID: 3733867 [TBL] [Abstract][Full Text] [Related]
14. Comparison of in vivo and in vitro activity of estrogen-linked nitrosoureas in methylnitrosourea-induced rat mammary carcinoma. Petru E; Berger MR; Kaufmann M J Cancer Res Clin Oncol; 1988; 114(3):317-20. PubMed ID: 3384846 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetic model and distribution pattern of new sexual-steroid-hormone-linked anticancer agents. Betsch B J Cancer Res Clin Oncol; 1990; 116(5):467-9. PubMed ID: 2229135 [TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. Marathe PH; Kamath AV; Zhang Y; D'Arienzo C; Bhide R; Fargnoli J Cancer Chemother Pharmacol; 2009 Dec; 65(1):55-66. PubMed ID: 19396600 [TBL] [Abstract][Full Text] [Related]
17. Antineoplastic efficacy of melphalan and N-(2-chloroethyl)-N-nitrosocarbamoyl-omega-lysine, in combination with diazoxide or insulin in autochthonous mammary carcinoma of the Sprague-Dawley rat. Klenner T; Berger MR; Zelezny O; Fink M; Schmähl D J Cancer Res Clin Oncol; 1990; 116(1):45-50. PubMed ID: 2107182 [TBL] [Abstract][Full Text] [Related]
18. Determination of tissue distribution of potent antitumor agent ureidomustin (BO-1055) by HPLC and its pharmacokinetic application in rats. Chien SI; Yen JC; Kakadiya R; Chen CH; Lee TC; Su TL; Tsai TH J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 917-918():62-70. PubMed ID: 23353940 [TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women. Baumann A; Fuhrmeister A; Brudny-Klöppel M; Draeger C; Bunte T; Kuhnz W Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877 [TBL] [Abstract][Full Text] [Related]
20. Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil. Genka S; Deutsch J; Shetty UH; Stahle PL; John V; Lieberburg IM; Ali-Osman F; Rapoport SI; Greig NH Clin Exp Metastasis; 1993 Mar; 11(2):131-40. PubMed ID: 8444006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]